drugset / Trial / NCT01234922

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

NCT01234922

Phase 2 Terminated 6 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Benazepril hydrochloride, lisinopril, ramipril, and losartan potassium may help lower blood pressure. PURPOSE: This phase II trial is studying how well benazepril hydrochloride, lisinopril, ramipril, or losartan potassium works in treating hypertension in patients with solid tumors.

Timeline

Start
2011-02
Primary completion
2013-12
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Benazepril Unknown Oral
Subject LISINOPRIL ANHYDROUS Small molecule Oral
Subject Losartan Other / unclassified Oral
Subject Ramipril Small molecule Oral